Pharmaceutical composition for used as combi-kit for effective management of luteal phase deficiency in women undergoing in-vivo fertilization procedure with Frozen Embryo Transfers or other fertility treatment, comprises dydrogesterone and progesterone and their salts
	SANJEEV J
	2023-07-26
专利权人	AKUMS DRUGS & PHARM LTD (AKUM-Non-standard)
申请日期	2023-07-26
专利号	IN202311042729-A
成果简介	NOVELTY - Pharmaceutical composition comprises dydrogesterone and progesterone and their salts. USE - Pharmaceutical composition for used as combi-kit (claimed) for effective management of luteal phase deficiency in women undergoing in-vivo fertilization procedure with Frozen Embryo Transfers or other fertility treatment. No biological data given. ADVANTAGE - The composition is drug delivery system which avoids drawbacks associated with current prescribed regimen and dosage form, provides sustained release of active agents thus reducing dose frequency, side effects and is more patient compliant; is simple, safe and improved dosage form which is superior then the current regimen; provide pre-determined release of the active agents with minimal side effects, reduces dose frequency and health care cost and avoid fluctuation in steady-state drug levels; provides a sustained release formulation which results in reduction of dose frequency and maintained a predetermined rate by maintaining a constant drug level for a specific period of time with minimum side effects. DETAILED DESCRIPTION - INDEPENDENT CLAIMS are included for: 1. a combi-kit comprising: 2-40 mg, preferably 10-20 mg sustained release dydrogesterone; and 100-1000 mg, preferably 200-400 mg sustained release progesterone; and 2. a tablet formulation comprising 10-20 mg sustained release dydrogesterone, and 200-400 mg sustained release progesterone.
IPC 分类号	A61K-031/567 ; A61K-031/585 ; A61K-045/06 ; A61K-009/20
国家	印度
专业领域	医药卫生
语种	英语
成果类型	专利
文献类型	科技成果
条目标识符	http://119.78.100.226:8889/handle/3KE4DYBR/21102
专题	中国科学院新疆生态与地理研究所
作者单位	AKUMS DRUGS & PHARM LTD (AKUM-Non-standard)
推荐引用方式 GB/T 7714	SANJEEV J. Pharmaceutical composition for used as combi-kit for effective management of luteal phase deficiency in women undergoing in-vivo fertilization procedure with Frozen Embryo Transfers or other fertility treatment, comprises dydrogesterone and progesterone and their salts. IN202311042729-A[P]. 2023.

条目包含的文件
条目无相关文件。

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。